4 unknown, 3 completed, 1 active not recruiting, 1 not yet recruiting. 3 Phase 2, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Not applicable | 2 | Active not recruiting 1, Unknown 1 |
Follow Differentiated Thyroid Carcinoma: new trials by email Literature Review of Differentiated Thyroid Carcinoma trials Research Report on Differentiated Thyroid Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bethesda Classification and Risk Stratification in Differentiated Thyroid Carcinoma Differentiated Thyroid Carcinoma, Papillary Thyroid Carcinoma | Not yet recruiting | Assiut University | 100 | 2026-10-26 | 2026-10-05 | |
| Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer ST-1898 tablets - Differentiated Thyroid Carcinoma | Phase 2 | Recruiting | Beijing Scitech-Mq Pharmaceuticals Limited | 60 | 2023-11-15 | 2026-11-05 |
| Correlation Between TCM Syndrome Factors and TSH Changes of Thyroid Hormone Withdrawal Before Iodine Therapy in Postoperative Patients With Thyroid Cancer Differentiated Thyroid Carcinoma, TCM Syndrome Type | Unknown | Qianfoshan Hospital | 160 | 2021-06-20 | 2021-06-16 | |
| Spanish Study for Molecular Characterization of Thyroid Carcinoma Immunohistochemistry (IHC), Fluorescence In-Situ Hybridization (FISH), Oncomine Focus Assay Platform with 52 genes - Differentiated Thyroid Carcinoma, Medullary Thyroid Carcinoma | Unknown | Grupo Español de Tratamiento de Tumores de Cabeza y Cuello | 150 | 2021-06-14 | 2024-09-19 | |
| Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients Renal Cell Carcinoma, Hepatocellular Carcinoma | Completed | Ipsen | 347 | 2019-05-15 | 2024-05-29 | |
| Significance of Contralateral Central Lymph Node Dissection in Unilateral cN0 Differentiated Thyroid Carcinoma. contralateral central lymph node dissection - Lymph Node Dissection, Lymph Node Metastases | Not applicable | Unknown | Fifth Affiliated Hospital, Sun Yat-Sen University | 50 | 2019-02-01 | 2020-11-24 |
| Phase 2 Trial of Apatinib Mesylate in Locally Advanced/Metastatic Differentiated Thyroid Carcinoma Apatinib Mesylate - Differentiated Thyroid Carcinoma | Phase 2 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 20 | 2017-03-22 | 2017-05-30 |
| I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer Radioiodine I-131, I-124 - Differentiated Thyroid Carcinoma | Not applicable | Active not recruiting | University of Wuerzburg | 340 | 2015-05-01 | 2026-10-09 |
| Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer Lithium Carbonate, Placebo - Thyroid Cancer, Differentiated Thyroid Carcinoma | Phase 2 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 34 | 2005-11-01 | 2013-02-04 |
| OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation Differentiated Thyroid Carcinoma | Completed | Oncology Institute of Southern Switzerland | 28 | 2005-01-01 | 2007-02-28 |
Thyroid Neoplasms (2) · Adenocarcinoma, Follicular (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Medullary (1) · Carcinoma, Renal Cell (1) · Lymphatic Metastasis (1) · Thyroid Cancer, Papillary (1) · Thyroid Nodule (1)
Neoplasms (6) · Neoplasms by Site (4) · Adenocarcinoma (3) · Carcinoma (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Head and Neck Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3) · Thyroid Diseases (3) · Adenocarcinoma, Papillary (1) · Carcinoma, Neuroendocrine (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Female Urogenital Diseases (1)
3-(3'-adamantan-1-yl-4'-methoxybiphenyl-4-yl)-2-propenoic acid (1) · High-Throughput Nucleotide Sequencing (1) · Immunohistochemistry (1) · In Situ Hybridization, Fluorescence (1) · Iodine-124 (1) · Lithium Carbonate (1) · apatinib (1)
Assiut University (1) · Beijing Scitech-Mq Pharmaceuticals Limited (1) · Fifth Affiliated Hospital, Sun Yat-Sen University (1) · Grupo Español de Tratamiento de Tumores de Cabeza y Cuello (1) · Ipsen (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Oncology Institute of Southern Switzerland (1) · Qianfoshan Hospital (1) · Tianjin Medical University Cancer Institute and Hospital (1) · University of Wuerzburg (1)
China (3) · Germany (1) · South Korea (1) · Spain (1) · United States (1)
Andreas Buck, MD, Prof. (1) · Ken Herrmann, MD, Prof. (1) · Lin Liao, Doctor (1) · Luca Giovanella, MD (1) · Ming Gao, MD (1) · Monica C Skarulis, M.D. (1) · Taha M Zaky, prof (1) · Yansong Lin, Ph D (1)